VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $9,180,000 | +46.0% | 395,000 | 0.0% | 0.85% | +65.9% |
Q1 2018 | $6,288,000 | -23.4% | 395,000 | 0.0% | 0.51% | -24.0% |
Q4 2017 | $8,208,000 | +45.0% | 395,000 | 0.0% | 0.67% | +29.5% |
Q3 2017 | $5,660,000 | -17.2% | 395,000 | 0.0% | 0.52% | -6.1% |
Q2 2017 | $6,834,000 | +56.9% | 395,000 | 0.0% | 0.55% | +56.2% |
Q1 2017 | $4,357,000 | -24.0% | 395,000 | 0.0% | 0.35% | -18.8% |
Q4 2016 | $5,735,000 | -40.9% | 395,000 | 0.0% | 0.44% | -49.9% |
Q3 2016 | $9,697,000 | +21.9% | 395,000 | 0.0% | 0.87% | +39.6% |
Q2 2016 | $7,955,000 | -23.4% | 395,000 | 0.0% | 0.62% | -31.7% |
Q1 2016 | $10,389,000 | -36.1% | 395,000 | +146.9% | 0.91% | -45.8% |
Q4 2015 | $16,264,000 | – | 160,000 | – | 1.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |